LV10106B - Products and their application of method for design and synthesis of enteinizing hormone releasing hormone antagonists - Google Patents

Products and their application of method for design and synthesis of enteinizing hormone releasing hormone antagonists Download PDF

Info

Publication number
LV10106B
LV10106B LVP-92-175A LV920175A LV10106B LV 10106 B LV10106 B LV 10106B LV 920175 A LV920175 A LV 920175A LV 10106 B LV10106 B LV 10106B
Authority
LV
Latvia
Prior art keywords
d3pal3
nac
molecule
ser4
leu7
Prior art date
Application number
LVP-92-175A
Other languages
English (en)
Latvian (lv)
Other versions
LV10106A (lv
Inventor
Shaobo Xiao
Original Assignee
Asta Medica Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asta Medica Ag filed Critical Asta Medica Ag
Publication of LV10106A publication Critical patent/LV10106A/xx
Publication of LV10106B publication Critical patent/LV10106B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/23—Luteinising hormone-releasing hormone [LHRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Endocrinology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicinal Preparation (AREA)
LVP-92-175A 1990-11-10 1992-10-27 Products and their application of method for design and synthesis of enteinizing hormone releasing hormone antagonists LV10106B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN90108955A CN1036343C (zh) 1990-11-10 1990-11-10 新促黄体生成素释放激素拮抗类似物的制备方法
PCT/EP1991/002110 WO1992008733A1 (en) 1990-11-10 1991-11-08 Lhrh-antagonists

Publications (2)

Publication Number Publication Date
LV10106A LV10106A (lv) 1994-05-10
LV10106B true LV10106B (en) 1995-04-20

Family

ID=4881223

Family Applications (1)

Application Number Title Priority Date Filing Date
LVP-92-175A LV10106B (en) 1990-11-10 1992-10-27 Products and their application of method for design and synthesis of enteinizing hormone releasing hormone antagonists

Country Status (29)

Country Link
EP (1) EP0564466B1 (pl)
KR (1) KR100244624B1 (pl)
CN (1) CN1036343C (pl)
AT (1) ATE149520T1 (pl)
AU (1) AU662496B2 (pl)
CA (1) CA2095932C (pl)
CZ (1) CZ284168B6 (pl)
DE (1) DE69125024T2 (pl)
DK (1) DK0564466T3 (pl)
EE (1) EE03141B1 (pl)
ES (1) ES2100965T3 (pl)
FI (1) FI933156A0 (pl)
GR (1) GR3023389T3 (pl)
HR (1) HRP920585B1 (pl)
IE (1) IE913915A1 (pl)
LT (1) LT3971B (pl)
LV (1) LV10106B (pl)
NO (1) NO931697L (pl)
NZ (1) NZ240505A (pl)
PH (1) PH31178A (pl)
PL (1) PL170564B1 (pl)
PT (1) PT99458B (pl)
RU (1) RU2123499C1 (pl)
SI (1) SI9111779B (pl)
SK (1) SK281319B6 (pl)
UA (1) UA41300C2 (pl)
WO (1) WO1992008733A1 (pl)
YU (1) YU48831B (pl)
ZA (1) ZA918847B (pl)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2136079A1 (en) * 1992-12-18 1994-07-07 Fortuna Haviv Lhrh antagonists having modified aminoacyl residues at positions 5 and 6
US6828415B2 (en) 1993-02-19 2004-12-07 Zentaris Gmbh Oligopeptide lyophilisate, their preparation and use
DE4305225A1 (de) * 1993-02-19 1994-08-25 Asta Medica Ag Neues Herstellverfahren für Cetrorelix Lyophilisat
DE4338015A1 (de) * 1993-11-08 1995-05-11 Asta Medica Ag Verwendung von D-glucopyranuronsäuren und deren Derivaten zum Einbau in pharmakologisch wirksame Peptide und deren Salze
US5843901A (en) * 1995-06-07 1998-12-01 Advanced Research & Technology Institute LHRH antagonist peptides
US5968547A (en) 1997-02-24 1999-10-19 Euro-Celtique, S.A. Method of providing sustained analgesia with buprenorphine
CN101037472B (zh) * 2006-03-14 2013-03-27 中国人民解放军军事医学科学院毒物药物研究所 具有低组胺释放作用的促黄体生成素释放激素拮抗剂
CN102675418B (zh) * 2011-03-15 2016-04-20 中国人民解放军军事医学科学院毒物药物研究所 Lhrh拮抗剂衍生物、其制备方法及用途
CN103524599B (zh) * 2012-07-05 2016-04-20 中国人民解放军军事医学科学院毒物药物研究所 环肽lhrh拮抗剂衍生物及其药物用途
CN104418936B (zh) * 2013-08-20 2018-06-05 中国人民解放军军事医学科学院毒物药物研究所 Lhrh拮抗剂衍生物及其药物用途

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4801577A (en) * 1987-02-05 1989-01-31 Syntex (U.S.A.) Inc. Nonapeptide and decapeptide analogs of LHRH useful as LHRH antagonists
US4851385A (en) * 1987-07-15 1989-07-25 Indiana University Foundation LHRH antagonist analogs having low histamine-release activity

Also Published As

Publication number Publication date
LT3971B (en) 1996-05-27
HRP920585B1 (en) 2000-08-31
RU2123499C1 (ru) 1998-12-20
PL295427A1 (en) 1993-09-06
PT99458B (pt) 1999-02-26
ATE149520T1 (de) 1997-03-15
FI933156A (fi) 1993-07-09
FI933156A0 (fi) 1993-07-09
CZ284168B6 (cs) 1998-09-16
SK45393A3 (en) 1993-10-06
EP0564466A1 (en) 1993-10-13
LTIP1513A (en) 1995-06-26
AU662496B2 (en) 1995-09-07
SK281319B6 (sk) 2001-02-12
CN1061605A (zh) 1992-06-03
UA41300C2 (uk) 2001-09-17
NO931697L (no) 1993-07-07
CA2095932C (en) 2003-02-25
YU177991A (sh) 1994-06-24
SI9111779B (en) 2001-12-31
KR930703353A (ko) 1993-11-29
IE913915A1 (en) 1992-05-20
KR100244624B1 (ko) 2000-02-15
CN1036343C (zh) 1997-11-05
PT99458A (pt) 1992-10-30
WO1992008733A1 (en) 1992-05-29
DE69125024T2 (de) 1997-07-17
EP0564466B1 (en) 1997-03-05
AU8861291A (en) 1992-06-11
YU48831B (sh) 2002-03-18
PL170564B1 (pl) 1996-12-31
DK0564466T3 (da) 1997-08-25
ES2100965T3 (es) 1997-07-01
NZ240505A (en) 1993-04-28
CZ84893A3 (en) 1994-02-16
NO931697D0 (no) 1993-05-10
CA2095932A1 (en) 1992-05-11
EE03141B1 (et) 1998-12-15
LV10106A (lv) 1994-05-10
GR3023389T3 (en) 1997-08-29
ZA918847B (en) 1992-08-26
PH31178A (en) 1998-03-20
DE69125024D1 (de) 1997-04-10
HRP920585A2 (en) 1997-04-30
SI9111779A (en) 1997-04-30

Similar Documents

Publication Publication Date Title
FI92326C (fi) LHRH:n nonapeptidi- ja dekapeptidianalogeja, jotka ovat käyttökelpoisia LHRH:n antagonisteina
RU2212247C2 (ru) Аналоги пептида лг-рф, их применение и содержащие их фармацевтические композиции
Rivier et al. Gonadotropin-releasing hormone antagonists with N. omega.-triazolylornithine,-lysine, or-p-aminophenylalanine residues at positions 5 and 6
US4253997A (en) Anti-ovulatory decapeptides
BR9808523B1 (pt) peptÍdeo antagonista de gnrh, composiÇço farmacÊutica para inibir a secreÇço de gonadotropinas em mamÍferos, e, intermediÁrio para fazer um peptÍdeo antagonista de gnrh.
Manning et al. Design of more potent and selective antagonists of the antidiuretic responses to arginine-vasopressin devoid of antidiuretic agonism
JPH08510205A (ja) Ｙｙペプチドのアナログとその用途
LV10106B (en) Products and their application of method for design and synthesis of enteinizing hormone releasing hormone antagonists
CA2112907C (en) Peptide which abrogates tnf and/or lps toxicity
SK278537B6 (en) Synthetic peptides, biologically active fragment and non-toxic synthetic peptide salt
IE74226B1 (en) GnRH Analogs
Haviv et al. The effect of NMeTyr5 substitution in luteinizing hormone-releasing hormone antagonists
CA1247599A (en) Mammalian pgrf
US6153587A (en) Conformationally constrained LH-RH analogues, their uses and pharmaceutical compositions containing them
Haviv et al. Stabilization of the N-terminal residues of luteinizing hormone-releasing hormone agonists and the effect on pharmacokinetics
US5480969A (en) Antagonists of LHRH
Kovacs et al. Long-term inhibition of ovulation by a GnRH-antagonist at low dose level
Haviv et al. In vitro and in vivo activities of reduced-size antagonists of luteinizing hormone-releasing hormone
Erchegi et al. LH-RH antagonists: further analogs with ring-substituted aromatic residues
Humphries et al. Peptide hormones. 137. Structural requirements in positions 1, 2, 3, and 6 of the luteinizing hormone-releasing hormone (LH-RH) for antiovulatory activity
Humphries et al. Nonapeptide ethylamide inhibitors of the luteinizing hormone-releasing hormone (LH-RH) having a D-alanyl residue in position 6 and variations at positions 2 and 3
US5783562A (en) Luteinizing hormone releasing hormone analogs
Seprődi et al. Potent GNRH agonists containing L-amino acid derivatives in the six position
AU697847B2 (en) Method for the treatment or prevention of eczema/dermatitis
Larsson et al. Solid phase synthesis and some hormonal activities of 8‐l‐homoarginine‐vasotocin and 1‐deamino‐8‐l‐homoarginine‐vasotocin